secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2023-07-13T23:59:59+00:00
Accession:  0001213900-23-056806
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Oramed stockholders re-elect all six director nominees and ratify auditor at 2023 annual meeting
--------------------------------------------------------------------------------

- Stockholders re-elected Miriam Kidron, Nadav Kidron, Arie Mayer, Yadin Rozov, Leonard Sank, Benjamin Shapiro as directors.
- Highest votes for Benjamin Shapiro (9,239,878 for); lowest for Leonard Sank (8,696,513 for); broker non-votes ~7.7M on each.
- Ratified Kesselman & Kesselman (PwC) as independent auditor for FY2023 with 16,991,347 for, 50,052 against, 71,751 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390023056806/0001213900-23-056806-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390023056806/ea181769-8k_oramedpharm.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-056806

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer